In the present study, after DMDD treatment, hepatic TGF-β, Smad2, and Smad3 were significantly downregulated, and COL1A1, α-SMA, and TIMP1 were key genes in liver fibrosis. The gene discussed is SMAD2; the disease is Hepatic fibrosis.